Stay updated on UNCOVER-2: Guselkumab Clinical Trial

Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the efficacy or safety assessment of ixekizumab (LY2439821) compared to etanercept and placebo in participants with moderate to severe chronic plaque psoriasis.
    Difference
    0.0%
    Check dated 2024-06-06T14:25:34.000Z thumbnail image
  5. Check
    7 days ago
    No Change Detected
  6. Check
    19 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants in the study, specifying both inclusion and exclusion criteria for chronic plaque psoriasis. Previously, no information was provided under the participation criteria section.
    Difference
    6%
    Check dated 2024-05-22T20:54:12.000Z thumbnail image
  7. Check
    41 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-04-30T22:41:14.000Z thumbnail image

Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.